Your prediction
Braskem Pfd ADR Stock
The Braskem Pfd ADR price is unchanged compared to yesterday.
Pros and Cons of Braskem Pfd ADR in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Braskem Pfd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Braskem Pfd ADR | 0.000% | 3.906% | 7.258% | -25.281% | 9.917% | -68.144% | -65.897% |
| Braskem Pfd A | -2.420% | 4.237% | 6.957% | -28.488% | 9.821% | -70.000% | -67.112% |
| Ingevity Corp | -0.710% | 3.728% | 8.798% | 44.171% | 11.389% | - | - |
| PTT Global Chemical -nvdr- | -2.540% | 4.425% | 11.321% | -7.813% | 6.306% | -57.554% | -66.092% |
Comments
Braskem S.A. (NYSE: BAK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating.
Show more
Ratings data for BAK provided by MarketBeat